Brief: Medicenna Therapeutics Says Net Loss For Quarter Ended December 31, 2020 Was C$5.3 Million
12/02/2021 12:18
Feb 12 (Reuters) - Medicenna Therapeutics Corp MDNA.TO :
* MEDICENNA REPORTS THIRD QUARTER FISCAL 2021 FINANCIAL
RESULTS
AND OPERATIONAL HIGHLIGHTS
* NET LOSS FOR QUARTER ENDED DECEMBER 31, 2020 WAS C$5.3
MILLION,
OR C$0.11 PER SHARE
Source text for Eikon: ID:nGNX8pMT7g
Further company coverage: MDNA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medicenna Therapeutics
See all newsBrief: Medicenna Therapeutics - Announces Two New U.S. Patents And One Allowed U.S. Patent Application
Brief: Medicenna Announces The Finalization Of The Terms Of Its Public Offering Of Securities
Brief: Medicenna Announces The Launch Of A Marketed Public Offering Of Securities
Brief: Medicenna Therapeutics Appoints Dr. Nageatte Ibrahim As Chief Medical Officer
Brief: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results